The new research and development (R&D) facility located in Hull, UK, will be used to test and manufacture a non-addictive alternative to methadone, designed to improve patient experience.
Boulting Environmental Services (BES) was the principal designer and principal contractor for the project, carrying out a complete turnkey package that included groundwork, piling, shell construction and the internal specialist architectural fit out of cleanrooms and laboratories.
The two-storey cGMP facility provides 5,000m2 of ISO Class 7 and ISO Class 8 product development cleanrooms and laboratories, along with highly specified offices, meeting rooms and a restaurant for staff.
Due to the nature of the facility, a full inspection from the Home Office was required after construction. The auditor not only gave the building approval, but referred to it as state-of-the-art — a testament to the quality of work that BES carried out on the site.
“BES completed the project three months ahead of schedule, within budget and to the highest quality,” explained Giles Singleton, Project Manager at BES.
“This was down to our lean programming framework and our ability to overlap different phases of the project to eliminate wasted time. At no point were our engineers waiting for one task to be completed before they could move on to the next. The entire process was efficient and streamlined with the customer’s requirements in mind at all times.”
“Indivior selected BES through a competitive tender process, in which BES came out on top in terms of cost-effectiveness and delivery time,” commented Paul O’Reilly, Facilities Director at Indivior.
“The design and build process was extremely collaborative, with BES listening to our primary objectives and creating a facility that was both technically fit-for-purpose and one that gave Indivior welcoming office space and recreational areas for staff.”